Synovial sarcoma (SS) is a highly malignant mesenchymal tumour that occurs mainly in adolescents and young adults [1], genetically defined by SS18 gene fusions including SS18–SSX1, SS18–SSX2, and SS18–SSX4. This evidence concerns the gene SSX4 and synovial sarcoma.